Meta-analysis · people
NMN: no significant benefit on blood sugar or lipids in pooled trials
Checked against the paper Meta-analysisPublished by PepVault
The takeaway
In mostly healthy middle-aged and older adults, short-term NMN did not significantly change blood sugar or blood fat markers across the trials pooled here.
- Kind
- Meta-analysis
- Studied in
- People
- Number studied
- 342
- Published
- 2024
- Journal
- Curr Diab Rep
What they tested
The team set out to test whether taking NMN improves markers of blood sugar control and blood fats in adults.
How the study was done
A systematic review and meta-analysis, which pools results across studies, of randomized controlled trials published in 2021-2023 with a total of 342 middle-aged and older adults, 49% of them women and mostly without diabetes. The trials gave 250-2000 mg/d of NMN for 14 days to 12 weeks.

What they found
Pooled across the trials, NMN showed no significant benefit on fasting glucose (blood sugar after not eating) or fasting insulin. It also showed no significant benefit on glycated hemoglobin, a longer-term blood sugar marker, or on the homeostatic model assessment for insulin resistance, a score of how well the body responds to insulin. The lipid profile, a panel of blood fats, showed no significant benefit either.
What it doesn’t show
Only a small number of trials were available, and they were short and mostly enrolled relatively healthy adults. The pooled results don't show what NMN does in people with diabetes or over longer use.
The paper
Chen et al. Effects of Nicotinamide Mononucleotide on Glucose and Lipid Metabolism in Adults: A Systematic Review and Meta-analysis of Randomised Controlled Trials. Curr Diab Rep. 2024.
The compound
More studies on NMN
- NMN raised serum nicotinamide over 12 weeks in middle-aged adultsRandomized trial · people · 2023
- NMN: raised blood NAD over 60 days in 80 middle-aged adultsRandomized trial · people · 2023
- NMN supplements raised blood NAD+ levels in healthy older menRandomized trial · people · 2022
- NMN raised muscle insulin sensitivity in women with prediabetesRandomized trial · people · 2021
- NMN: aerobic gains at 600 and 1200 mg/day in amateur runnersRandomized trial · people · 2021
- Every study on NMN
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.